Singapore markets closed

Profound Medical Corp. (PROF)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
7.99+0.29 (+3.77%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close7.70
Open7.85
Bid5.56 x 200
Ask7.99 x 100
Day's range7.63 - 7.99
52-week range7.11 - 15.49
Volume10,017
Avg. volume39,709
Market cap195.187M
Beta (5Y monthly)0.79
PE ratio (TTM)N/A
EPS (TTM)-1.35
Earnings date09 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est12.61
  • GlobeNewswire

    Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow

    TORONTO, April 22, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its first quarter 2024 financial results after market close on Thursday, May 9, 2024. Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the

  • GlobeNewswire

    Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference

    TORONTO, April 09, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2024 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 16, 2024 at 9:30 a.m. Eastern Time at the Metro Toronto Convention Centre.

  • Simply Wall St.

    Shareholders in Profound Medical (TSE:PRN) are in the red if they invested three years ago

    If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. Long...